Page 3 - Inflammation Biology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inflammation biology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inflammation Biology Today - Breaking & Trending Today

Investegate |Syncona Limited Announcements | Syncona Limited: New commitment to Quell in largest ever Series A

11 February 2021
·
Further commitment of £25.3 million in a £61.0 million expanded Series A; taking Syncona s total commitment to Quell to £59.3 million
·
First company globally targeting liver transplantation with engineered T regulatory cell therapy; set for clinical entry in the first half of 2022

·
Research programmes initiated in Type 1 Diabetes ( T1D ) and Amyotrophic Lateral Sclerosis ( ALS )
Syncona Ltd ( Syncona ) announces a £25.3 million new commitment in a £61.0 million expanded Series A financing for Quell Therapeutics ( Quell ). This is the largest amount of funding to date for any stand-alone engineered T regulatory cell (Treg) company and this new commitment takes Syncona s total commitment to this business to £59.3 million. Syncona has invested £35.1 million of its total commitment and values its investment at that amount (equivalent to cost). Syncona will have a ....

City Of , United Kingdom , Iain Mcgill , Collins Tim Stamper , Martin Murphy , Hans Stauss , Marc Martinez Llordella , Giovanna Lombardi , Alberto Sanchez Fueyo , Emma Morris , Annabel Clay , Ben Atwell Natalie , Elmar Jaeckel , University College London , Department Of Gastroenterology , Syncona Investment Management , Hannover Medical School , Institute Of Immunity , Syncona Ltd , Institute Of Liver , University Of Sheffield , Group Leader , Sheffield Institute For Translational Neuroscience Sitra , Amyotrophic Lateral Sclerosis , Quell Therapeutics , Sheffield Institute ,

Quell Therapeutics Expands Series A Financing to $84 Million

Quell Therapeutics Expands Series A Financing to $84 Million
Search jobs
Quell Therapeutics Expands Series A Financing to $84 Million
– Largest Series A in the Treg field –

London, UK – February 11 2021 – Quell Therapeutics Ltd (“Quell”), a biotechnology company developing engineered T regulatory (Treg) cell therapies, today announced the closing of an extended Series A financing led by their existing investors Syncona Ltd (“Syncona”), who have committed an additional $34.7 million and UCL Technology Fund (“UCLTF”) who have committed an additional $1 million; bringing the total Series A financing to circa $84 million.

Quell is funded to progress its program in liver transplantation to clinical proof of concept, whilst expanding its portfolio into autoimmune and neuroinflammatory diseases. Additionally, the funding will allow the Company to further develop scalable manufacturing processes and expand its senior le ....

United Kingdom , City Of , Alberto Sanchez Fueyo , Iain Mcgill , Martin Murphy , Elmar Jaeckel , King College London , University College London , Kings College London , Department Of Gastroenterology , Syncona Investment Management , Therapeutics Ltd , Hannover Medical School , Syncona Ltd , University Of Sheffield , St Thoma , Sheffield Institute For Translational Neuroscience Sitra , Technology Fund , Quell Therapeutics Expands Series , Largest Series , Quell Therapeutics Ltd , Amyotrophic Lateral Sclerosis , Motor Neuron Disease , Modular Engineered Treg , Syncona Investment Management Limited , Inflammation Biology ,

QIMR Berghofer partners with MedAir Australia to test SARS-CoV-2 aerosol removal technology

QIMR Berghofer Medical Research Institute has entered into a collaborative R&D agreement with Australian start-up company, MedAir Australia, to test a. ....

Karl Lijun Qin , Andreas Suhrbier , Berghofer Medical Research Institute , Laboratory In Queensland , Queensland Health , Institute Inflammation Biology , Qimr Berghofer Medical Research Institute , Medical Research Institute , Medair Australia , Inflammation Biology , Professor Andreas Suhrbier , Qimr Berghofer , Medical Research , Covid 19 , பெர்கோஃபர் மருத்துவ ஆராய்ச்சி நிறுவனம் , ஆய்வகம் இல் குயின்ஸ்லாந்து , குயின்ஸ்லாந்து ஆரோக்கியம் , மருத்துவ ஆராய்ச்சி நிறுவனம் , மருத்துவ ஆராய்ச்சி ,